Fairchem Organics Q1 FY27 Revenue Jumps 34.4% to ₹176 Crore, EBITDA at ₹18 Crore
Fairchem Organics reported Q1 FY27 revenue of ₹176 crore, up 34.4% YoY, with EBITDA at ₹18 crore and net profit at ₹10 crore. Revenue growth was driven by higher price realization due to elevated raw material costs and reduced imports. The company processed 12,400 tonnes and sold 13,500 tonnes. Capacity utilization is targeted to reach 70-75% by FY27.
The substantial revenue growth and improved profitability, coupled with positive management commentary on future prospects, are likely to have a significant positive impact on investor sentiment and the company's stock performance.
The company reported significant year-on-year revenue growth, improved EBITDA margins, and a positive outlook attributed to favorable market conditions and strategic initiatives.
Fairchem Organics Limited reported a strong performance for the first quarter of FY27, with revenue from operations reaching ₹176 crore, marking a significant 34.4% year-on-year increase. The company achieved an EBITDA of ₹18 crore, with an EBITDA margin of 10.14%, and a net profit of ₹10 crore. During the quarter, Fairchem processed 12,400 tonnes of raw material and sold 13,500 tonnes.
The revenue growth was driven by higher price realization, attributed to elevated raw material costs and reduced imports amid supply chain constraints. The company noted that improved domestic market realization and easing import pressure supported the EBITDA margins. Looking ahead, Fairchem is optimistic about its trajectory, expecting favorable tariff developments with the US and the depreciation of the Indian Rupee to strengthen export competitiveness and support improved capacity utilization.
The revenue mix for Q1 FY27 comprised 30% dimer acid, 42% linoleic acid, 4% Isostearic acid, and 24% other by-products. The company plans to maintain similar revenue and margin run rates for the remainder of the fiscal year. Regarding Isostearic acid, Fairchem anticipates reaching over 80% capacity utilization within the next 1-2 years. The company has also implemented energy conservation measures, reducing power consumption by over 30% and solid fuel consumption by more than 35%, alongside continuous efforts to optimize catalyst usage and manpower.
Fairchem is exploring new product development, with a new oleochemical product slated for introduction next quarter, developed in-house. The company is focused on manufacturing products that are difficult to produce, rather than solely on patents. While specific customer details and sales volumes are confidential, the company confirmed that dimer acid is made from vegetable oil sources. The new 40,000 metric ton capacity, expected from Q2, is for an oleochemical product with potentially better margins than current offerings. The company aims to increase capacity utilization from the current 60% to 70-75% by the end of FY27. Exports currently contribute 7-8% of revenue, with Dimer and Isostearic acid identified as key products for export growth. The paint industry accounts for 40% of the company's domestic revenue, a proportion Fairchem does not intend to reduce. Realizations have improved by approximately 25% from Q4 FY26 and 30% from Q1 FY26, a trend expected to sustain as long as the West Asia crisis persists and Chinese dumping remains subdued. The company is working towards increasing its overall capacity utilization and is comfortable with current margin levels.
What to do with a filing like this
Fairchem Organics Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fairchem Organics Limited. Read the original for the full detail.